肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

癌症筛查说明书

2016-10-12 爱康国宾 爱康国宾

癌症筛查
关注



版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1507132, encodeId=d483150e13265, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536129, encodeId=8e26153612979, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147377, encodeId=63b814e37755, content=学习了，赞一个！, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Thu Oct 13 09:28:15 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147233, encodeId=24a414e23371, content=不全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Wed Oct 12 23:05:25 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146729, encodeId=4270146e298d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:37:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146728, encodeId=8a83146e288f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:36:54 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-14 yangpeizhi

    #说明书#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1507132, encodeId=d483150e13265, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536129, encodeId=8e26153612979, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147377, encodeId=63b814e37755, content=学习了，赞一个！, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Thu Oct 13 09:28:15 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147233, encodeId=24a414e23371, content=不全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Wed Oct 12 23:05:25 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146729, encodeId=4270146e298d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:37:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146728, encodeId=8a83146e288f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:36:54 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-14 yangwen5713

    #癌症筛查#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1507132, encodeId=d483150e13265, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536129, encodeId=8e26153612979, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147377, encodeId=63b814e37755, content=学习了，赞一个！, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Thu Oct 13 09:28:15 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147233, encodeId=24a414e23371, content=不全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Wed Oct 12 23:05:25 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146729, encodeId=4270146e298d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:37:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146728, encodeId=8a83146e288f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:36:54 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-13 lietome1

    学习了，赞一个！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1507132, encodeId=d483150e13265, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536129, encodeId=8e26153612979, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147377, encodeId=63b814e37755, content=学习了，赞一个！, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Thu Oct 13 09:28:15 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147233, encodeId=24a414e23371, content=不全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Wed Oct 12 23:05:25 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146729, encodeId=4270146e298d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:37:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146728, encodeId=8a83146e288f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:36:54 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-12 1e0bc67dm33(暂无匿称)

    不全面

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1507132, encodeId=d483150e13265, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536129, encodeId=8e26153612979, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147377, encodeId=63b814e37755, content=学习了，赞一个！, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Thu Oct 13 09:28:15 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147233, encodeId=24a414e23371, content=不全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Wed Oct 12 23:05:25 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146729, encodeId=4270146e298d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:37:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146728, encodeId=8a83146e288f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:36:54 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-12 doctorJiangchao

    继续关注

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1507132, encodeId=d483150e13265, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536129, encodeId=8e26153612979, content=<a href='/topic/show?id=d0c6e1458e2' target=_blank style='color:#2F92EE;'>#癌症筛查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71458, encryptionId=d0c6e1458e2, topicName=癌症筛查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46ed12663026, createdName=yangwen5713, createdTime=Fri Oct 14 02:43:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147377, encodeId=63b814e37755, content=学习了，赞一个！, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=841a1636000, createdName=lietome1, createdTime=Thu Oct 13 09:28:15 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147233, encodeId=24a414e23371, content=不全面, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a431926374, createdName=1e0bc67dm33(暂无匿称), createdTime=Wed Oct 12 23:05:25 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146729, encodeId=4270146e298d, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:37:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=146728, encodeId=8a83146e288f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Oct 12 12:36:54 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-12 doctorJiangchao

    继续学习

    0

相关资讯

Nature子刊：眼睛是什么颜色，可能决定了你的患癌风险

导语：通过眼睛颜色来判断癌症？这不是不可能，研究人员在Nature子刊上证明了眼睛颜色和葡萄膜黑色素瘤之间的基因关联性。一项研究揭示，特定的遗传差异与葡萄膜黑色素瘤的风险有关，相关研究结果发表在《 Scientific Reports》杂志上。该报告的数据表明，与眼睛、皮肤色素相关的遗传因素可增加其患葡萄膜黑色素瘤的风险。葡萄膜黑色素瘤是一种由色素细胞滋生的罕见黑色素瘤，在美国每年大约有2500人

2016JSPM临床指南——癌症患者呼吸道症状治疗建议发布

2016年6月，日本姑息医学会(JSPM)发布了癌症患者呼吸道症状治疗建议指南，该指南针对癌症患者呼吸道症状的管理共提出26条循证建议。全文获取：下载地址：指南下载 (需要扣积分2分, 梅斯医学APP免积分下载) 

2017NCCN临床实践指南——癌症和化疗诱导的贫血（2017.V1）发布

2016年10月，美国国家综合癌症网络(NCCN)发布了癌症和化疗诱导的贫血指南。全文获取：下载地址：指南下载 (需要扣积分2分, 梅斯医学APP免积分下载) 

全新发现：22种癌症属于遗传疾病！

哈佛大学科学家与丹麦和芬兰研究员合作进行的研究发现，至少有22种癌症属于遗传疾病，会在家族之间世代相传。根据这项大型研究的结果，大约三分之一的癌症是遗传的。家族遗传风险最高的包括前列腺癌、乳腺癌、肺癌和肠癌。 哈佛大学科学家与丹麦和芬兰研究员合作进行的研究发现，至少有22种癌症属于遗传疾病，会在家族之间世代相传。 根据这项大型研究的结果，大约三分之一的癌症是遗传

Cell子刊：老年痴呆的致病蛋白，或许可以用于治疗癌症

导语：近期，《Developmental Cell》期刊发表一篇文章揭示，淀粉样蛋白可以让细胞进入休眠状态。当癌细胞中存储大量淀粉样蛋白时，它处于休眠状态。但是，热休克信号通路会降解这类蛋白，从而使得癌细胞“苏醒”，促使其增殖、扩散。对于阿尔兹海默症而言，淀粉样蛋白的存在通常是不好的预示，因为β-淀粉样蛋白是构成大脑老年斑的主要组成物质，是检测患病程度的重要指标之一，同时也是老年痴呆免疫疗法的关键

癌症转移重大发现：K离子，氧气，T细胞和免疫抑制密切关联

美国国家癌症研究中心终身研究员Nicholas P. Restifo博士，他在癌症免疫基础研究方面获得了不少重要成果。他们研究组刚刚发现了肺脏中抗癌免疫反应受到抑制的机制。这一机制与氧气抑制T细胞的抗癌活性有关。采用遗传方法或药物来抑制免疫细胞的氧感应能力可以阻止肺转移。这一研究成果公布在Cell杂志上。同时，还发现细胞外K离子浓度对T细胞受体（TCR）驱动的AKT-mTOR磷酸化的作用，从而抑制